ADAM10 expression and promoter haplotype in Alzheimer's disease. - Wikidata - awgldk - TriplyDB

ADAM10 expression and promoter haplotype in Alzheimer's disease.

ADAM10 expression and promoter haplotype in Alzheimer's disease.

http://www.wikidata.org/entity/Q36080855

about

Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population.An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis.Promoter Variants of the ADAM10 Gene and Their Roles in Temporal Lobe Epilepsy.Nardilysin in human brain diseases: both friend and foe.Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.The Role of ADAM10 in Alzheimer's Disease.Shedding the epilepsy comorbidity in Alzheimer's disease.Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.Genetic association between APP, ADAM10 gene polymorphism, and sporadic Alzheimer's disease in the Chinese population.ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics

P2860

Q26738884-2DE0DD7E-3D1B-4539-A20D-972C08ED3415 Q34522042-6CA0DECE-B94A-4680-99C9-434BEECE82B2 Q35215527-654C4349-FCC9-4345-A537-1134096FBFA8 Q37054395-21E68866-2A0A-49A1-A99C-E50FDAA61935 Q38100617-0E80BD11-1551-46DB-BAEF-CB1A57DE930B Q39052950-2273571A-FE7F-4951-B987-E374C13A5221 Q39242629-8BB09286-5415-4CAA-80FA-B2B1079CB70A Q42102583-D4D6FE68-D1B5-4B69-A8C1-51D52B0B5EE2 Q45741541-2586B0BE-03A5-46D5-BF99-0C14F947E6CC Q47908768-EF793AEB-A30C-4DC5-8496-328240371A5B Q53361177-C30FFB63-8129-4B19-AC3F-637CA909C0DC Q53366645-52E980A9-A5AA-4321-AC93-4CE9FC0BD7E6 Q57134342-41DF22E6-0C8D-49EC-92A7-68F7945E3201

P2860

ADAM10 expression and promoter haplotype in Alzheimer's disease.

http://www.wikidata.org/entity/Q36080855

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@ast

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@en

type

label

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@ast

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@en

prefLabel

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@ast

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@en

P1433

Q36080855-0E09E02C-BB1E-4BF1-B389-BD10FF2E2471

P1476

Q36080855-67BD06CA-F9FE-41C7-AD2F-8DE80F217713

P2093

Q36080855-194E3C14-1570-4BE3-96E0-F40EF9890EF3

Q36080855-2EC46804-6BCA-4A51-9FEE-F4599297392F

Q36080855-40F03CD1-E2A6-42CE-9D36-E7271D82894B

Q36080855-7C340B27-3646-46CF-9699-2ECEF30D3350

Q36080855-B399A642-89E5-4167-8B4F-B40221E159BE

Q36080855-E4543562-0C1E-44B0-8B78-488AA3BD206E

Q36080855-EC57F041-3C36-4EBE-A36B-B2C12E656063

Q36080855-F4521047-9A56-4F43-B9EC-A25322CD7B15

P2860

Q36080855-02200B1C-B32B-4F31-88DD-285CF6C66150

Q36080855-0355F7EC-2775-414E-843E-E298D3A6ECE6

Q36080855-08AA7500-9C9F-4689-A89A-C58CD7CBE6BB

Q36080855-0A554D90-E556-498F-87BC-75AF562962C8

Q36080855-0AEF968F-FD04-4467-962F-D1ACFB42A2C5

Q36080855-0DEEF5EE-0608-45B2-AEAC-4DA978FC7AC3

Q36080855-167AF2A9-7F72-411F-83B2-AB1C6C7F905E

Q36080855-1C9CE9D4-2010-408B-A386-C52020E74C30

Q36080855-2CB93319-E6DC-492E-BC84-9DF2B6D600DE

Q36080855-37E6A85D-55E5-4641-931F-C3C7E8D34998

P304

Q36080855-7A9BE9C1-049B-4C4D-9573-95060A83B2BB

P31

Q36080855-95AA7F7F-3147-4615-B7AC-88B498387D3D

P356

Q36080855-370B4077-A7F1-41A2-B24C-8209F9A8B5F0

P433

Q36080855-95DE8537-C951-4A03-8A29-C49577C7E19D

P478

Q36080855-EFB12B8E-1E3D-47CF-889D-442978F9D1B4

P50

Q36080855-39583E9B-166F-4B1F-B802-08F5B7518386

Q36080855-5511187A-ECDE-44DA-8986-D385909A1D73

Q36080855-AD2849DE-7A69-4954-8216-AAD5582997EE

Q36080855-C0D17381-EDA4-4F09-9A1C-36221E561EFB

P577

Q36080855-8A502235-99A6-485C-82B5-E275DC756935

P698

Q36080855-79DEA7F6-47DF-46ED-AD4B-52957644C1CE

P932

Q36080855-BBB27CA1-4521-46F1-91B5-BF70B7047042

P356

J.NEUROBIOLAGING.2012.03.013

P1433

Neurobiology of Aging

P1476

ADAM10 expression and promoter haplotype in Alzheimer's disease.

@en

P2093

Chang-En Yu

http://www.w3.org/2001/XMLSchema#string

Douglas R Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Franziska Lutz

http://www.w3.org/2001/XMLSchema#string

Gail Li

http://www.w3.org/2001/XMLSchema#string

Lynn M Bekris

http://www.w3.org/2001/XMLSchema#string

Martin R Farlow

http://www.w3.org/2001/XMLSchema#string

Thomas J Montine

http://www.w3.org/2001/XMLSchema#string

P2860

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Haploview: analysis and visualization of LD and haplotype maps

Mild cognitive impairment: clinical characterization and outcome

Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus

α-Secretase Activity of the Disintegrin Metalloprotease ADAM 10: Influences of Domain Structure

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease.

P304

2229.e1-2229.e9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2012.03.013

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

James B Leverenz

P577

2012-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22572541

http://www.w3.org/2001/XMLSchema#string

P932

3391324

http://www.w3.org/2001/XMLSchema#string